Business Context and Reporting Period
This Form 8-K reports on the results of the 2020 Annual Meeting of Stockholders held by IDEAYA Biosciences, Inc. on June 16, 2020. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol IDYA. As of the record date (April 17, 2020), 20,401,848 shares of common stock were outstanding and entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting:
- Proposal 1 (Election of Director): The election of Yujiro Hata as a Class I director was approved.
- Votes For: 12,670,530
- Votes Withheld: 381,286
- Broker Non-Votes: 3,106,257
- Proposal 2 (Ratification of Auditors): The ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ending December 31, 2020, was approved.
- Votes For: 16,151,274
- Votes Against: 1,421
- Abstentions: 5,378
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the tabulation of stockholder votes.
Key Facts for Investor Verification
- Yujiro Hata was elected as a Class I director to serve until the 2023 annual meeting.
- PricewaterhouseCoopers LLP was ratified as the independent auditor for the 2020 fiscal year.
- Approximately 15.2% of outstanding shares were withheld from voting on the director election (381,286 votes withheld out of 20,401,848 outstanding).
- Broker non-votes accounted for approximately 15.2% of the total outstanding shares on the director election proposal.